|
Dec 1
|
UCB presents new data advancing patient-focused scientific leadership at American Epilepsy Society Annual Meeting
|
|
Oct 18
|
BIMZELX® Approved by the U.S. FDA for the Treatment of Adults with Moderate-to-Severe Plaque Psoriasis
|
|
Oct 17
|
UCB announces U.S. FDA approval of ZILBRYSQ® (zilucoplan) for the treatment of adults with generalized myasthenia gravis
|